Search
Our new and improved patient folder is a comprehensive resource to help families navigate a new type 1 diabetes diagnosis, now and into the future.
Discover essential insights on food and nutrition for Type 1 Diabetes, from carb counting to meal planning.
Pump Comparison tool . This easy-to-use updated comparison tool is designed to help you pick the right device for your family.
Websites we think you'll find useful.
Find out how to participate in our research and community groups.
We are in a new era of T1D care. We can now identify and provide care for people across a spectrum of T1D, from early-stage T1D to symptomatic insulin requiring T1D (Stage 3 and Stage 4). And for the first time since the discovery of insulin over 100 years ago, Australia has approved a new therapy, Teplizumab.
T1D can be a traumatic diagnosis for children and young people, and often involves strict adherence to painful treatments, comorbid mental health conditions, and shortened life expectancy.
The DiabHQ Patient Portal app is now available to WA children and families living with Type 1 diabetes.
Continuous glucose monitoring (CGM) can detect early dysglycemia in older children and adults with presymptomatic type 1 diabetes and predict risk of progression to clinical onset. However, CGM data for very young children at greatest risk of disease progression are lacking.
The Environmental Determinants of Islet Autoimmunity Study is an ongoing Australian prospective cohort study investigating how modifiable prenatal and early-life exposures drive the development of islet autoimmunity and type 1 diabetes in children. In this profile, we describe the cohort's parental demographics, maternal and neonatal outcomes and human leukocyte antigen genotypes.